Hypoxia inducible factor stabilization leads to lasting improvement of hippocampal memory in healthy mice

Behavioural Brain Research

Volumn 208, Issue 1, 2010, Pages 80-84

  Adamcio, Bartosz ^a,b   Sperling, Swetlana ^a   Hagemeyer, Nora ^a   Walkinshaw, Gail ^c   Ehrenreich, Hannelore ^a,b  

^a MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^b Deutsche Forschungsgemeinschaft   (Germany)

^c FIBROGEN INC   (United States)

Author keywords

EPO; Erythropoietin; Fear conditioning test; FG 4497; VEGF

Indexed keywords

ENZYME INHIBITOR; ERYTHROPOIETIN; FG 4497; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; UNCLASSIFIED DRUG; VASCULOTROPIN; ERYTHROPOIETIN RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1; VASCULOTROPIN A;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; BRAIN TISSUE; COGNITION; CONTROLLED STUDY; ERYTHROPOIETIN GENE; GENE; GENE EXPRESSION; HEMATOCRIT; HIPPOCAMPUS; IMMUNOBLOTTING; MALE; MEMORY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; UPREGULATION; VASCULOTROPIN GENE; ANALYSIS OF VARIANCE; ANIMAL; AUDITORY STIMULATION; C57BL MOUSE; CELL CULTURE; CONDITIONED REFLEX; CYTOLOGY; DRUG EFFECT; FEAR; GENETICS; METABOLISM; METHODOLOGY; NERVE CELL; NEWBORN; PHYSIOLOGY; TIME;

ACOUSTIC STIMULATION; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; CELLS, CULTURED; CONDITIONING, CLASSICAL; ENZYME INHIBITORS; ERYTHROPOIETIN; FEAR; HEMATOCRIT; HIPPOCAMPUS; HYPOXIA-INDUCIBLE FACTOR 1; MALE; MEMORY; MICE; MICE, INBRED C57BL; NEURONS; RECEPTORS, ERYTHROPOIETIN; RNA, MESSENGER; TIME FACTORS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77951933535     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2009.11.010     Document Type: Article

References (21)

1. Adamcio B., Sargin D., Stradomska A., Medrihan L., Gertler C., Theis F., et al. Erythropoietin enhances hippocampal long-term potentiation and memory. BMC Biol 2008, 6:37.
2. Brines M., Cerami A. Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci 2005, 6:484-494.
3. Cao L., Jiao X., Zuzga D.S., Liu Y., Fong D.M., Young D., et al. VEGF links hippocampal activity with neurogenesis, learning and memory. Nat Genet 2004, 36:827-835.
4. Ehrenreich H., Degner D., Meller J., Brines M., Behe M., Hasselblatt M., et al. Erythropoietin: a candidate compound for neuroprotection in schizophrenia. Mol Psychiatry 2004, 9:42-54.
5. Ehrenreich H., Fischer B., Norra C., Schellenberger F., Stender N., Stiefel M., et al. Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis. Brain 2007, 130:2577-2588.
6. Ehrenreich H., Hinze-Selch D., Stawicki S., Aust C., Knolle-Veentjer S., Wilms S., et al. Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. Mol Psychiatry 2007, 12:206-220.
7. El-Kordi A., Radyushkin K., Ehrenreich H. Erythropoietin improves operant conditioning and stability of cognitive performance in mice. BMC Biol 2009, 7:37.
8. Hsieh M.M., Linde N.S., Wynter A., Metzger M., Wong C., Langsetmo I., et al. HIF prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques. Blood 2007, 110:2140-2147.
9. Jelkmann W. Erythropoietin after a century of research: younger than ever. Eur J Haematol 2007, 78:183-205.
10. Kim B.W., Choi M., Kim Y.S., Park H., Lee H.R., Yun C.O., et al. Vascular endothelial growth factor (VEGF) signaling regulates hippocampal neurons by elevation of intracellular calcium and activation of calcium/calmodulin protein kinase II and mammalian target of rapamycin. Cell Signal 2008, 20:714-725.
11. Knabe W., Knerlich F., Washausen S., Kietzmann T., Siren A.L., Brunnett G., et al. Expression patterns of erythropoietin and its receptor in the developing midbrain. Anat Embryol (Berl) 2004, 207:503-512.
12. Milosevic J., Adler I., Manaenko A., Schwarz S.C., Walkinshaw G., Arend M., et al. Non-hypoxic stabilization of hypoxia-inducible factor alpha (HIF-alpha): relevance in neural progenitor/stem cells. Neurotox Res 2009, 15:367-380.
13. Pati S., Orsi S.A., Moore A.N., Dash P.K. Intra-hippocampal administration of the VEGF receptor blocker PTK787/ZK222584 impairs long-term memory. Brain Res 2009, 1256:85-91.
14. Plaschke K., Staub J., Ernst E., Marti H.H. VEGF overexpression improves mice cognitive abilities after unilateral common carotid artery occlusion. Exp Neurol 2008, 214:285-292.
15. Schneider C., Krischke G., Keller S., Walkinshaw G., Arend M., Rascher W., et al. Short-term effects of pharmacologic HIF stabilization on vasoactive and cytotrophic factors in developing mouse brain. Brain Res 2009, 1280:43-51.
16. Semenza G.L. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 2000, 88:1474-1480.
17. Semenza G.L. Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology (Bethesda) 2004, 19:176-182.
18. Sharp F.R., Bernaudin M. HIF1 and oxygen sensing in the brain. Nat Rev Neurosci 2004, 5:437-448.
19. Siddiq A., Ayoub I.A., Chavez J.C., Aminova L., Shah S., LaManna J.C., et al. Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous system. J Biol Chem 2005, 280:41732-41743.
20. Siren A.L., Knerlich F., Poser W., Gleiter C.H., Bruck W., Ehrenreich H. Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol 2001, 101:271-276.
21. Witten L., Sager T., Thirstrup K., Johansen J.L., Larsen D.B., Montezinho L.P., et al. HIF prolyl hydroxylase inhibition augments dopamine release in the rat brain in vivo. J Neurosci Res 2009, 87:1686-1694.